美股異動 | AMC院線盤前漲近1.5% 擬買下美國東部7座影院及66塊屏幕
格隆匯4月13日 | AMC院線(AMC.US)盤前漲1.49%,報17.68美元,總市值91億美元。消息面上,AMC院線持續推進其影院收購戰略,在位於美國東部的康涅狄格州和紐約州等三個州收購了7座影院和66塊屏幕。據悉,這筆交易的對象為Bow Tie Cinemas。公司表示,將於4月21日至22日在其中四個新址開始營業,其餘的將在未來幾周內開業。該公司表示,其在康涅狄格州的業務增加了一倍多。該公司首席執行官Adam Aron表示,公司正在逐步走向復甦。此前,Adam Aron表示,正計劃進行更多的戰略交易,以利用去年從散户投資者那裏籌集到的10億餘美元中的部分資金。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.